Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

Importance of free water in controlling granule and tablet properties in a novel granulation method, green fluidized bed granulation (GFBG).

Takasaki H, Sakurai A, Katayama T, Matsuura Y, Ohyagi N, Mizoguchi M, Takano J, Wada K, Matsui K, Nagato T, Ishikawa A, Yonemochi E.

Int J Pharm. 2019 Oct 30;570:118647. doi: 10.1016/j.ijpharm.2019.118647. Epub 2019 Aug 26.

PMID:
31465838
2.

PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma.

Hirata-Nozaki Y, Ohkuri T, Ohara K, Kumai T, Nagata M, Harabuchi S, Kosaka A, Nagato T, Ishibashi K, Oikawa K, Aoki N, Ohara M, Harabuchi Y, Uno Y, Takei H, Celis E, Kobayashi H.

J Transl Med. 2019 Jun 20;17(1):207. doi: 10.1186/s12967-019-1957-5.

3.

A proliferation-inducing ligand (APRIL) induced hyper-production of IgA from tonsillar mononuclear cells in patients with IgA nephropathy.

Takahara M, Nagato T, Nozaki Y, Kumai T, Katada A, Hayashi T, Harabuchi Y.

Cell Immunol. 2019 Jul;341:103925. doi: 10.1016/j.cellimm.2019.103925. Epub 2019 May 8.

4.

Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: Basic Science and Clinical Progress.

Harabuchi Y, Takahara M, Kishibe K, Nagato T, Kumai T.

Front Pediatr. 2019 Apr 16;7:141. doi: 10.3389/fped.2019.00141. eCollection 2019. Review.

5.

Characterization of Amorphous Solid Dispersion of Pharmaceutical Compound with pH-Dependent Solubility Prepared by Continuous-Spray Granulator.

Tanaka R, Hattori Y, Horie Y, Kamada H, Nagato T, Otsuka M.

Pharmaceutics. 2019 Apr 3;11(4). pii: E159. doi: 10.3390/pharmaceutics11040159.

6.

Subglottic Stenosis in Granulomatosis With Polyangiitis.

Nagato T, Kishibe K, Harabuchi Y.

Am J Med Sci. 2019 Apr;357(4):e13-e14. doi: 10.1016/j.amjms.2019.01.005. Epub 2019 Jan 12. No abstract available.

PMID:
30904050
7.

A large-scale experimental comparison of batch and continuous technologies in pharmaceutical tablet manufacturing using ethenzamide.

Matsunami K, Nagato T, Hasegawa K, Sugiyama H.

Int J Pharm. 2019 Mar 25;559:210-219. doi: 10.1016/j.ijpharm.2019.01.028. Epub 2019 Jan 22.

8.

Cyclin-dependent kinase 1 and survivin as potential therapeutic targets against nasal natural killer/T-cell lymphoma.

Nagato T, Ueda S, Takahara M, Kishibe K, Komabayashi Y, Kumai T, Ohara K, Hirata-Nozaki Y, Harabuchi S, Hayashi R, Ohkuri T, Bernasconi M, Nadal D, Kobayashi H, Harabuchi Y.

Lab Invest. 2019 May;99(5):612-624. doi: 10.1038/s41374-018-0182-9. Epub 2019 Jan 21.

PMID:
30664711
9.

The route of administration dictates the immunogenicity of peptide-based cancer vaccines in mice.

Sultan H, Kumai T, Nagato T, Wu J, Salazar AM, Celis E.

Cancer Immunol Immunother. 2019 Mar;68(3):455-466. doi: 10.1007/s00262-018-02294-5. Epub 2019 Jan 2.

PMID:
30604041
10.

Targeting phosphorylated p53 to elicit tumor-reactive T helper responses against head and neck squamous cell carcinoma.

Ohara K, Ohkuri T, Kumai T, Nagato T, Nozaki Y, Ishibashi K, Kosaka A, Nagata M, Harabuchi S, Ohara M, Oikawa K, Aoki N, Harabuchi Y, Celis E, Kobayashi H.

Oncoimmunology. 2018 Aug 1;7(9):e1466771. doi: 10.1080/2162402X.2018.1466771. eCollection 2018.

11.

Treatment outcome and prognostic factors of tonsillectomy for palmoplantar pustulosis and pustulotic arthro-osteitis: A retrospective subjective and objective quantitative analysis of 138 patients.

Takahara M, Hirata Y, Nagato T, Kishibe K, Katada A, Hayashi T, Kishibe M, Ishida-Yamamoto A, Harabuchi Y.

J Dermatol. 2018 Jul;45(7):812-823. doi: 10.1111/1346-8138.14348. Epub 2018 May 6.

PMID:
29732605
12.

Effects of STING stimulation on macrophages: STING agonists polarize into "classically" or "alternatively" activated macrophages?

Ohkuri T, Kosaka A, Nagato T, Kobayashi H.

Hum Vaccin Immunother. 2018 Feb 1;14(2):285-287. doi: 10.1080/21645515.2017.1395995. Epub 2017 Dec 1.

13.

Intratumoral injection of IFN-β induces chemokine production in melanoma and augments the therapeutic efficacy of anti-PD-L1 mAb.

Uehara J, Ohkuri T, Kosaka A, Ishibashi K, Hirata Y, Ohara K, Nagato T, Oikawa K, Aoki N, Harabuchi Y, Ishida-Yamamoto A, Kobayashi H.

Biochem Biophys Res Commun. 2017 Aug 19;490(2):521-527. doi: 10.1016/j.bbrc.2017.06.072. Epub 2017 Jun 15.

PMID:
28624449
14.

Programmed death-ligand 1 and its soluble form are highly expressed in nasal natural killer/T-cell lymphoma: a potential rationale for immunotherapy.

Nagato T, Ohkuri T, Ohara K, Hirata Y, Kishibe K, Komabayashi Y, Ueda S, Takahara M, Kumai T, Ishibashi K, Kosaka A, Aoki N, Oikawa K, Uno Y, Akiyama N, Sado M, Takei H, Celis E, Harabuchi Y, Kobayashi H.

Cancer Immunol Immunother. 2017 Jul;66(7):877-890. doi: 10.1007/s00262-017-1987-x. Epub 2017 Mar 27.

PMID:
28349165
15.

Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor site.

Ohkuri T, Kosaka A, Ishibashi K, Kumai T, Hirata Y, Ohara K, Nagato T, Oikawa K, Aoki N, Harabuchi Y, Celis E, Kobayashi H.

Cancer Immunol Immunother. 2017 Jun;66(6):705-716. doi: 10.1007/s00262-017-1975-1. Epub 2017 Feb 27.

PMID:
28243692
16.

Up-regulation of CX3CR1 on tonsillar CD8-positive cells in patients with IgA nephropathy.

Otaka R, Takahara M, Ueda S, Nagato T, Kishibe K, Nomura K, Katada A, Hayashi T, Harabuchi Y.

Hum Immunol. 2017 Apr;78(4):375-383. doi: 10.1016/j.humimm.2017.02.004. Epub 2017 Feb 11.

PMID:
28196748
17.

Circulating Epstein-Barr virus-encoded micro-RNAs as potential biomarkers for nasal natural killer/T-cell lymphoma.

Komabayashi Y, Kishibe K, Nagato T, Ueda S, Takahara M, Harabuchi Y.

Hematol Oncol. 2017 Dec;35(4):655-663. doi: 10.1002/hon.2360. Epub 2016 Oct 6.

PMID:
27709652
18.

Epigenetic modification augments the immunogenicity of human leukocyte antigen G serving as a tumor antigen for T cell-based immunotherapy.

Ishibashi K, Kumai T, Ohkuri T, Kosaka A, Nagato T, Hirata Y, Ohara K, Oikawa K, Aoki N, Akiyama N, Sado M, Kitada M, Harabuchi Y, Celis E, Kobayashi H.

Oncoimmunology. 2016 Mar 30;5(6):e1169356. doi: 10.1080/2162402X.2016.1169356. eCollection 2016 Jun.

19.

Novel treatment for early-stage nasal natural killer/T-cell lymphoma: intra-maxillary arterial infusion chemotherapy with concomitant radiotherapy.

Takahara M, Nagato T, Kishibe K, Ueda S, Komabayashi Y, Yamashina M, Takahashi K, Harabuchi Y.

Hematol Oncol. 2017 Jun;35(2):158-162. doi: 10.1002/hon.2273. Epub 2015 Nov 13.

PMID:
26563973
20.

Targeting HER-3 to elicit antitumor helper T cells against head and neck squamous cell carcinoma.

Kumai T, Ohkuri T, Nagato T, Matsuda Y, Oikawa K, Aoki N, Kimura S, Celis E, Harabuchi Y, Kobayashi H.

Sci Rep. 2015 Nov 5;5:16280. doi: 10.1038/srep16280.

21.

CCL17 and CCL22/CCR4 signaling is a strong candidate for novel targeted therapy against nasal natural killer/T-cell lymphoma.

Kumai T, Nagato T, Kobayashi H, Komabayashi Y, Ueda S, Kishibe K, Ohkuri T, Takahara M, Celis E, Harabuchi Y.

Cancer Immunol Immunother. 2015 Jun;64(6):697-705. doi: 10.1007/s00262-015-1675-7. Epub 2015 Mar 10.

22.

A novel combinatorial cancer immunotherapy: poly-IC and blockade of the PD-1/PD-L1 pathway.

Nagato T, Celis E.

Oncoimmunology. 2014 May 15;3:e28440. eCollection 2014.

23.

Combinatorial immunotherapy of polyinosinic-polycytidylic acid and blockade of programmed death-ligand 1 induce effective CD8 T-cell responses against established tumors.

Nagato T, Lee YR, Harabuchi Y, Celis E.

Clin Cancer Res. 2014 Mar 1;20(5):1223-34. doi: 10.1158/1078-0432.CCR-13-2781. Epub 2014 Jan 3.

24.

A novel approach to monitor coating amount by short-wavelength near-infrared spectroscopy using a tracer with a long-chain hydrocarbyl group.

Ozawa T, Yokoyama M, Hosono T, Nagato T, Tahara K, Takeuchi H.

Int J Pharm. 2013 Dec 15;458(1):9-14. doi: 10.1016/j.ijpharm.2013.10.015. Epub 2013 Oct 19.

PMID:
24148662
25.

Downregulation of miR-15a due to LMP1 promotes cell proliferation and predicts poor prognosis in nasal NK/T-cell lymphoma.

Komabayashi Y, Kishibe K, Nagato T, Ueda S, Takahara M, Harabuchi Y.

Am J Hematol. 2014 Jan;89(1):25-33. doi: 10.1002/ajh.23570. Epub 2013 Sep 30.

26.

Soluble ICAM-1 secretion and its functional role as an autocrine growth factor in nasal NK/T cell lymphoma cells.

Takahara M, Nagato T, Komabayashi Y, Yoshino K, Ueda S, Kishibe K, Harabuchi Y.

Exp Hematol. 2013 Aug;41(8):711-8. doi: 10.1016/j.exphem.2013.03.009. Epub 2013 Apr 10.

PMID:
23583640
27.

Detection of component segregation in granules manufactured by high shear granulation with over-granulation conditions using near-infrared chemical imaging.

Koide T, Nagato T, Kanou Y, Matsui K, Natsuyama S, Kawanishi T, Hiyama Y.

Int J Pharm. 2013 Jan 30;441(1-2):135-45. doi: 10.1016/j.ijpharm.2012.12.005. Epub 2012 Dec 12.

PMID:
23247019
28.

Expression of CD70 in nasal natural killer/T cell lymphoma cell lines and patients; its role for cell proliferation through binding to soluble CD27.

Yoshino K, Kishibe K, Nagato T, Ueda S, Komabayashi Y, Takahara M, Harabuchi Y.

Br J Haematol. 2013 Feb;160(3):331-42. doi: 10.1111/bjh.12136. Epub 2012 Dec 4.

PMID:
23206232
29.

Congenital cholesteatoma isolated to the mastoid presenting as stricture of the external auditory canal.

Nagato T, Otaka R, Wada T, Kanai N, Harabuchi Y.

Int J Pediatr Otorhinolaryngol. 2012 May;76(5):754-6. doi: 10.1016/j.ijporl.2012.02.032. Epub 2012 Mar 3.

PMID:
22390902
30.

Clinical images: Eagle's syndrome.

Nagato T, Ohara K, Takahara M, Hayashi T, Harabuchi Y.

Arthritis Rheum. 2012 May;64(5):1561. doi: 10.1002/art.34418. No abstract available.

31.

Immunohistochemical and Immunocytochemical Localization of Amylase in Rat Parotid Glands and von Ebner's Glands by Ion Etching-Immunoscanning Electron Microscopy.

Yahiro J, Inai T, Tsutsui A, Sato A, Nagato T, Taniguchi K, Tsuruga E, Sawa Y.

Acta Histochem Cytochem. 2011 Oct 26;44(5):201-12. doi: 10.1267/ahc.10039. Epub 2011 Aug 10.

32.

Right-sided pyriform sinus fistula.

Nagato T, Otaka R, Wada T, Kanai N, Harabuchi Y.

Intern Med J. 2011 Nov;41(11):798. doi: 10.1111/j.1445-5994.2011.02594.x. No abstract available.

PMID:
22077946
33.

Monocytes enhance cell proliferation and LMP1 expression of nasal natural killer/T-cell lymphoma cells by cell contact-dependent interaction through membrane-bound IL-15.

Ishii H, Takahara M, Nagato T, Kis LL, Nagy N, Kishibe K, Harabuchi Y, Klein E.

Int J Cancer. 2012 Jan 1;130(1):48-58. doi: 10.1002/ijc.25969. Epub 2011 May 25.

34.

Expression of B7-H3 in hypopharyngeal squamous cell carcinoma as a predictive indicator for tumor metastasis and prognosis.

Katayama A, Takahara M, Kishibe K, Nagato T, Kunibe I, Katada A, Hayashi T, Harabuchi Y.

Int J Oncol. 2011 May;38(5):1219-26. doi: 10.3892/ijo.2011.949. Epub 2011 Feb 22.

PMID:
21344157
35.

Quantification of umu genotoxicity level of urban river water.

Kameya T, Nagato T, Nakagawa K, Yamashita D, Kobayashi T, Fujie K.

Water Sci Technol. 2011;63(3):410-5. doi: 10.2166/wst.2011.235.

PMID:
21278461
36.

Primary small cell carcinoma of lacrimal sac: case report and literature review.

Goto T, Bandoh N, Nagato T, Takahara M, Harabuchi Y, Tokusashi Y, Miyokawa N.

J Laryngol Otol. 2010 Nov;124(11):1223-6. doi: 10.1017/S0022215110000940. Epub 2010 Apr 23. Review.

PMID:
20412615
37.

Laryngeal plexiform schwannoma as first symptom in a patient with neurofibromatosis type 2.

Nagato T, Katada A, Yoshizaki T, Kunibe I, Takahara M, Katayama A, Hayashi T, Harabuchi Y.

Clin Neurol Neurosurg. 2010 Jul;112(6):505-8. doi: 10.1016/j.clineuro.2010.02.010. Epub 2010 Mar 29.

PMID:
20303213
38.

Characterization of human CD4 helper T cell responses against Aurora kinase A.

Kobayashi H, Azumi M, Hayashi S, Sato K, Aoki N, Kimura S, Kakizaki H, Nagato T, Harabuchi Y, Tateno M, Celis E.

Cancer Immunol Immunother. 2010 Jul;59(7):1029-39. doi: 10.1007/s00262-010-0826-0. Epub 2010 Feb 25.

PMID:
20182874
39.

Production of interferon-{gamma}-inducible protein-10 and its role as an autocrine invasion factor in nasal natural killer/T-cell lymphoma cells.

Moriai S, Takahara M, Ogino T, Nagato T, Kishibe K, Ishii H, Katayama A, Shimizu N, Harabuchi Y.

Clin Cancer Res. 2009 Nov 15;15(22):6771-9. doi: 10.1158/1078-0432.CCR-09-1052. Epub 2009 Nov 3.

40.

Nasal natural killer (NK)/T-cell lymphoma: clinical, histological, virological, and genetic features.

Harabuchi Y, Takahara M, Kishibe K, Moriai S, Nagato T, Ishii H.

Int J Clin Oncol. 2009 Jun;14(3):181-90. doi: 10.1007/s10147-009-0882-7. Epub 2009 Jul 11. Review.

PMID:
19593607
41.

Clinical images: Otitis media and nasal granulation in Wegener's granulomatosis.

Nagato T, Otaka R, Wada T, Kanai N, Harabuchi Y.

Arthritis Rheum. 2009 Feb;60(2):379. doi: 10.1002/art.24327. No abstract available.

42.

Expression and functional role of MDL-1 (CLEC5A) in mouse myeloid lineage cells.

Aoki N, Kimura Y, Kimura S, Nagato T, Azumi M, Kobayashi H, Sato K, Tateno M.

J Leukoc Biol. 2009 Mar;85(3):508-17. doi: 10.1189/jlb.0508329. Epub 2008 Dec 12.

PMID:
19074552
43.

Energy transmission transformer for a wireless capsule endoscope: analysis of specific absorption rate and current density in biological tissue.

Shiba K, Nagato T, Tsuji T, Koshiji K.

IEEE Trans Biomed Eng. 2008 Jul;55(7):1864-71. doi: 10.1109/TBME.2008.919721.

PMID:
18595805
44.

Induction of EBV-latent membrane protein 1-specific MHC class II-restricted T-cell responses against natural killer lymphoma cells.

Kobayashi H, Nagato T, Takahara M, Sato K, Kimura S, Aoki N, Azumi M, Tateno M, Harabuchi Y, Celis E.

Cancer Res. 2008 Feb 1;68(3):901-8. doi: 10.1158/0008-5472.CAN-07-3212.

45.

Analysis of specific absorption rate and current density in an energy transmission system for a wireless capsule endoscope.

Shiba K, Nagato T, Tsuji T, Koshiji K.

Conf Proc IEEE Eng Med Biol Soc. 2007;2007:6052-5.

PMID:
18003394
46.

Selected amino acid change encoding Epstein-Barr virus-specific T cell epitope of the LMP2A gene in Japanese nasal NK/T cell lymphoma patients.

Nagamine M, Kishibe K, Takahara M, Nagato T, Ishii H, Bandoh N, Ogino T, Harabuchi Y.

Intervirology. 2007;50(5):319-22. Epub 2007 Jul 26.

PMID:
17657160
47.

Recognition of prostate and melanoma tumor cells by six-transmembrane epithelial antigen of prostate-specific helper T lymphocytes in a human leukocyte antigen class II-restricted manner.

Kobayashi H, Nagato T, Sato K, Aoki N, Kimura S, Murakami M, Iizuka H, Azumi M, Kakizaki H, Tateno M, Celis E.

Cancer Res. 2007 Jun 1;67(11):5498-504.

48.

Clinical usefulness of serum EBV DNA levels of BamHI W and LMP1 for Nasal NK/T-cell lymphoma.

Ishii H, Ogino T, Berger C, Köchli-Schmitz N, Nagato T, Takahara M, Nadal D, Harabuchi Y.

J Med Virol. 2007 May;79(5):562-72.

PMID:
17385697
49.

Effects of TNF-alpha on leukocyte adhesion molecule expressions in cultured human lymphatic endothelium.

Sawa Y, Sugimoto Y, Ueki T, Ishikawa H, Sato A, Nagato T, Yoshida S.

J Histochem Cytochem. 2007 Jul;55(7):721-33. Epub 2007 Mar 19.

PMID:
17371935
50.

Functional analysis of birch pollen allergen Bet v 1-specific regulatory T cells.

Nagato T, Kobayashi H, Yanai M, Sato K, Aoki N, Oikawa K, Kimura S, Abe Y, Celis E, Harabuchi Y, Tateno M.

J Immunol. 2007 Jan 15;178(2):1189-98.

Supplemental Content

Loading ...
Support Center